5 independently checked trend briefs about this subject, newest first.
headlinez.news detected 5 source-qualified news clusters connected to Medscape between June 23, 2026 and July 28, 2026. They span 1 newsroom category and average 7.0 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
A new study shocks couples by linking a spouse’s dementia diagnosis to a 70‑plus percent jump in their own dementia risk.
Recent research and medical commentary explore the evolving role of GLP-1 receptor agonists in oncology, sparking debate over their efficacy and risks.
New analysis indicates that popular weight-loss medications may not deliver the anticipated improvements in mental health or employment outcomes.
New research suggests high-dose DHA omega-3 supplements do not effectively prevent memory decline or reduce the risk of Alzheimer's disease.
Emerging research links GLP-1 weight-loss medications to potential improvements in male fertility, including increased testosterone and sperm counts.